Manufacturing FDA imposes import alert on Indian plant after inspectors flag GMP failings BioSpaceOfficials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant.Read full story pharminent June 12, 2026 (Last updated: June 17, 2026) BioSpace Officials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novo Nordisk comeback stirs as Wegovy pill wins UK approvalNext: Next Post Related Stories Manufacturing pharminent June 17, 2026 Manufacturing Eisai claims UK grant to expand manufacturing site pharminent June 15, 2026 Manufacturing Cellares and TScan to assess automated manufacturing of TSC-101 therapy pharminent June 4, 2026
